Andrew Tsai
Stock Analyst at Jefferies
(3.29)
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics | Maintains: Buy | 40 35 | 20.06 | 74.48% | 3 | Jul 24, 2025 | |
STOK Stoke Therapeutics | Initiates Coverage On: Buy | 30 | 19.68 | 52.44% | 1 | Jul 18, 2025 | |
BBIO BridgeBio Pharma | Initiates Coverage On: Buy | 70 | 50.23 | 39.36% | 1 | Jul 14, 2025 | |
VRNA Verona Pharma | Maintains: Strong Buy | 95 110 | 105.45 | 4.31% | 1 | Jun 11, 2025 | |
RCKT Rocket Pharmaceutica... | Downgrades: Hold | 29 3 | 3.73 | -32.98% | 2 | May 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 200 | 117.14 | 70.74% | 1 | Apr 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 19 27 | 18.32 | 47.38% | 2 | Mar 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 5 1 | 0.55 | -9.09% | 1 | Oct 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 4 13 | 0.61 | 2031.15% | 2 | Sep 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 14.93 | 134.43% | 1 | Jul 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 21 | 21.55 | -2.55% | 1 | Mar 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 33 | 3.58 | 821.79% | 1 | Feb 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 1 15 | 3.06 | 390.2% | 2 | Dec 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 3 | 1.17 | 156.41% | 1 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 32 3 | n/a | n/a | 2 | Jun 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | 8.05 | 148.45% | 1 | Feb 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 70 | 131.87 | -46.92% | 2 | Sep 20, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 27 | 4.39 | 515.03% | 1 | Sep 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 44.96 | -59.96% | 1 | Nov 23, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 16 23 | 38.18 | -39.76% | 1 | Jun 1, 2020 |